Neurofibromatosis Clinical Trials 2022

Browse 43 Neurofibromatosis Medical Studies Across 130 Cities

3 Phase 3 Trial · 491 Neurofibromatosis Clinics

Reviewed by Michael Gill, B. Sc.
25 Neurofibromatosis Clinical Trials Near Me
Boston, MA
Rochester, MN
New York, NY
Baltimore, MD
More Trial Locations
An interactive map to display trial locations for Massachusetts General Hospital, Mayo Clinic Hospital - Rochester, New York University Langone Medical Center, Johns Hopkins Hospital, and 246 more locations.
Most Popular References for Neurofibromatosis Clinical Trials
Frequency
Citation
Top Hospitals for Neurofibromatosis Clinical Trials
Location
Active Neurofibromatosis Clinical Trials
All Time Trials for Neurofibromatosis
First Recorded Neurofibromatosis Trial
Trials
National Institutes of Health Clinical Center, Bethesda, Maryland
9
20
2005
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
7
18
2001
Top Treatments for Neurofibromatosis Clinical Trials
Top Cities for Neurofibromatosis Clinical Trials
City
Active Neurofibromatosis Clinical Trials
Top Active Site for Neurofibromatosis Clinical Trials
Trial List
Boston, Massachusetts
17
Massachusetts General Hospital
New York, New York
16
Memorial Sloan Kettering Cancer Center
Bethesda, Maryland
16
National Institutes of Health Clinical Center
Most Recent Neurofibromatosis Clinical Trials
Phase 3 Neurofibromatosis Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
6/20/2022
Phase 2 & 3
Pediatric Neurofibromatosis Clinical Trials
Senior Friendly Neurofibromatosis Clinical Trials

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 17th, 2021

Last Reviewed: August 9th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.